Evaluation of the Efficacy of a New Inactivated Vaccine Against Ovine Enzootic Abortion

Home Knowledge Evaluation of the Efficacy of a New Inactivated Vaccine Against Ovine Enzootic Abortion

Evaluation of the Efficacy of a New Inactivated Vaccine Against Ovine Enzootic Abortion

The aim of this study was to test a new inactivated vaccine against Ovine enzootic abortion (OEA) that has recently been commercialized in different European countries under the name INMEVA®.

About this article

Appeared in

Frontiers in Veterinary Science, 2020

Date

Sep 4, 2020

Authors

Montbrau, C. ; Fontseca, M. ; Ortega, N. ; Caro, M.R. ; Benavides, J. ; Salinas, J. ; March, R ; Sitjà, M.

Summary

The results obtained in this study have shown that the INMEVA commercial inactivated vaccine is safe, showing a suitable level of protection against OEA related to a significant decrease in reproductive failures and in chlamydial shedding, thereby limiting spread of infection in the flock.

Related products

Share this on

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}